Skip to main content

Biophotonics Market Projected Expansion to $133.9+ Billion Market Value by 2030 with a 10.5% CAGR During 2021-2030



Allied Market Research published a report, titled, "Biophotonics Market By End User (Medical Diagnostics, Medical Therapeutics, Tests & Components, and Nonmedical Application) and Application (See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy, Analytical Sensing, and Biosensors): Global Opportunity Analysis and Industry Forecast, 2021-2030." According to the report, the global biophotonics industry generated $52.17 billion in 2020, and is expected to reach $133.90 billion by 2030, witnessing a CAGR of 10.5% from 2021 to 2030.

The emergence of nanotechnology, R&D activities in the field of optics, and surge in use of biophotonic devices for medical & nonmedical purposes drive the growth of the global biophotonics market. However, high cost of equipment restrains the market growth. Contrarily, the use of biophotonics in non-medical sectors is expected to present opportunities for the market.

The Medical Diagnostics Segment to Maintain its Dominant Share during the forecast period

Based on end use, the medical diagnostics segment accounted for the highest market share in 2020, contributing to nearly three-fifths of the global biophotonics market, and is projected to maintain its dominant share in terms of revenue during the forecast period. This is due to technological advancements in the field of diagnostics, rise in incidences of chronic diseases, and surge in awareness about healthcare. However, the non-medical segment is estimated to witness the highest CAGR of 13.4% from 2021 to 2030, owing to increase in use in life science, agriculture, environmental science, and microscopy.

The Analytics Sensing Segment to continue its Lead Position Throughout the Forecast Period

Based on application, the analytics sensing segment held the highest market share in 2020, accounting for more than one-fourth of the global biophotonics market, and is projected to continue its lead position throughout the forecast period. This is attributed to the widespread usage of this application. However, the microscopy segment is estimated to register the largest CAGR of 11.5% from 2021 to 2030, owing to high-throughput techniques and the digitization of microscopes.

North America to Maintain its Leadership Status by 2030

Based on region, North America contributed to the highest market share in terms of revenue in 2020, accounting for more than one-third of the global biophotonics market, and is expected to maintain its leadership status by 2030. This is due to increased use in the medical sector for therapy and non-medical applications. However, Asia-Pacific is projected to portray the fastest CAGR of 11.8% during the forecast period, owing to technological advancements and development of new products by leading market players in the region.



Bio Photonics Research Award


Visit: biophotonicsresearch.com
Nominate Now: https://biophotonicsresearch.com/award-nomination/?ecategory=Awards&rcategory=Awardee

#MeatAnalysis #FluorescenceTech #FoodQuality #FoodSafety #SpectroscopyInFood #MeatAuthentication #RapidDetection #FoodScience #MeatFreshness #MolecularDetection #FoodIndustryInnovation #NonDestructiveTesting #FoodMonitoring #SpectroscopyApplications #QualityControl #AdvancedSpectroscopy #MeatSpoilageDetection #FoodIntegrity #SmartFoodTesting #RealTimeAnalysis #FoodAuthenticity #FoodSafetyInnovation #SpectroscopyResearch #NextGenFoodSafety #InnovativeFoodScience,

Comments

Popular posts from this blog

Abrisa Technologies Acquires Agama Glass Technologies

SANTA PAULA, Calif. — Abrisa Technologies, a provider of custom glass optics and thin film coatings and a subsidiary of HEF Photonics, has acquired Agama Glass Technologies, a manufacturer of etched anti-glare glass and technical glass processing. The acquisition, Abrisa said, expands its manufacturing footprint and adds a vertically integrated solution for chemically etched anti-glare display glass. According to Abrisa, Clarksburg, West Virginia-based Agama operates North America’s only high-volume technical glass etching facility. Agama's flagship product, AgamaEtch, is used in high-performance display and optics applications. The company's 85,000 sq ft facility also offers precision glass fabrication, chemical strengthening, and silk-screen printing, serving markets such as avionics, defense, medical, industrial, and touchscreen displays. Combined with Abrisa Technologies’ and HEF Photonics’ thin-film coating and surface engineering capabilities, Agama's offerings wi...

How Biophotonics Is Harnessing Light for Health And Science

Fifty or so years ago French physicist Pierre Aigrain coined the term photonics as a research field whose goal was to use light to perform functions that traditionally fell within the typical domain of electronics, such as telecommunications, and information processing. Or maybe it was John Campbell who, in a letter sent to Gotthard Gunther in 1954, wrote, “Incidentally, I’ve decided to invent a new science — photonics. It bears the same relationship to Optics that electronics does to electrical engineering. Photonics, like electronics, will deal with the individual units; optics and EE deal with the group phenomena! And note that you can do things with electronics that are impossible in electrical engineering!” Naming rights aside, the field of photonics began in earnest between 1958 and 1960 with the invention of the maser and the laser. The laser diode followed during the 1970s, optical fibers and the erbium-doped fiber amplifier after that, and, pretty soon, the telecommunications...

Laser Method Enables Fast & Precise Blood Vessels in Hydrogel

Researchers from Vienna University of Technology (TU Wien) and Keio University have found a way to create artificial blood vessels in miniature organ models in a quick and reproducible manner. The method utilizes ultrashort laser pulses in the femtosecond range to write highly 3D structures into a hydrogel. In biomedical research, organs-on-a-chip are becoming increasingly important: By cultivating tissue structures in precisely controlled microfluidic chips, it is possible to conduct research much more accurately than in experiments involving living humans or animals. However, there has been a major obstacle: such mini-organs are incomplete without blood vessels. To facilitate systematic studies and ensure meaningful comparisons with living organisms, a network of perfusable blood vessels and capillaries must be created — in a way that is precisely controllable and reproducible. “We can create channels spaced only a hundred micrometers apart. That’s essential when you would like to...